ACTILYSE TREATMENT-SET 50mg/VIAL

Product Information

Registration Status: Active

ACTILYSE TREATMENT-SET 50mg/VIAL is approved to be sold in Singapore with effective from 1988-03-10. It is marketed by BOEHRINGER INGELHEIM SINGAPORE PTE LTD, with the registration number of SIN02340P.

This product contains Recombinant Human Tissue-Type Plasminogen Activator 50mg/vial in the form of INJECTION, POWDER, FOR SOLUTION. It is approved for INTRAVENOUS use.

This product is manufactured by BOEHRINGER INGELHEIM PHARMA GMBH & CO KG in GERMANY.

It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.

Recombinant Human Tissue-Type Plasminogen Activator


Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.

References

  1. Health Science Authority of Singapore - Reclassified POM
  2. Drugbank